10.3760/cma.j.issn.1673-422X.2015.04.019
Sheng-Neng-Quan- Yang-Yi- Wang-Zhi-Gang
Abstract
Sheng-Neng-Quan- Yang-Yi- Wang-Zhi-Gang
Abstract
Gastrointestinal neuroendocrine tumor (GI-NET) originates from peptide neurons and neuroendocrine cells in gastrointestinal tract, and secrets peptide hormones, leading to carcinoid syndrome which rarely happens in clinical practice. Because of the improvement of diagnostic method and understanding of this rare disease, the morbidity is rising in recent years. The main treatments of GI-NET are surgery and comprehensive therapy, consisting of chemotherapy and targeted therapy. Key words: Gastrointestinal tract; Neuroendocrine tumors; Diagnostic evaluation; Therapeutics
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gastrointestinal neuroendocrine tumor (GI-NET) originates from peptide neurons and neuroendocrine cells in gastrointestinal tract, and secrets peptide hormones, leading to carcinoid syndrome which rarely happens in clinical practice. Because of the improvement of diagnostic method and understanding of this rare disease, the morbidity is rising in recent years. The main treatments of GI-NET are surgery and comprehensive therapy, consisting of chemotherapy and targeted therapy. Key words: Gastrointestinal tract; Neuroendocrine tumors; Diagnostic evaluation; Therapeutics
Key concepts: Neuroendocrine tumors, Gastrointestinal tract, Carcinoid syndrome, Medicine, Digestive tract, Disease, Chemotherapy, Octreotide